The clustered regularly interspaced short palindromic repeats(CRISPR)/CRISPR-associated protein 9(Cas9)system is an acquired immune system of many bacteria and archaea,comprising CRISPR loci,Cas genes,and its associat...The clustered regularly interspaced short palindromic repeats(CRISPR)/CRISPR-associated protein 9(Cas9)system is an acquired immune system of many bacteria and archaea,comprising CRISPR loci,Cas genes,and its associated proteins.This system can recognize exogenous DNA and utilize the Cas9 protein's nuclease activity to break DNA double-strand and to achieve base insertion or deletion by subsequent DNA repair.In recent years,multiple laboratory and clinical studies have revealed the therapeutic role of the CRISPR/Cas9 system in neurological diseases.This article reviews the CRISPR/Cas9-mediated gene editing technology and its potential for clinical application against neurological diseases.展开更多
The authors regret that an error occurred to the affiliations of the first author in the original article.An corrigendum is given as follow:Haibin Jianga,b,Mengyan Tangc,Zidi Xub,Yanan Wangb,Mopu Lib,Shuyin Zhengb,Jia...The authors regret that an error occurred to the affiliations of the first author in the original article.An corrigendum is given as follow:Haibin Jianga,b,Mengyan Tangc,Zidi Xub,Yanan Wangb,Mopu Lib,Shuyin Zhengb,Jianghu Zhua,d,e,f,∗,Zhenlang Lina,d,e,f,∗,Min Zhanga,d,e,f,∗a Department of Pediatrics,the Second School of Medicine,the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University,Wenzhou,Zhejiang 325027,China.展开更多
基金funded by the National Natural Science Foundation of China(No.82271747).
文摘The clustered regularly interspaced short palindromic repeats(CRISPR)/CRISPR-associated protein 9(Cas9)system is an acquired immune system of many bacteria and archaea,comprising CRISPR loci,Cas genes,and its associated proteins.This system can recognize exogenous DNA and utilize the Cas9 protein's nuclease activity to break DNA double-strand and to achieve base insertion or deletion by subsequent DNA repair.In recent years,multiple laboratory and clinical studies have revealed the therapeutic role of the CRISPR/Cas9 system in neurological diseases.This article reviews the CRISPR/Cas9-mediated gene editing technology and its potential for clinical application against neurological diseases.
文摘The authors regret that an error occurred to the affiliations of the first author in the original article.An corrigendum is given as follow:Haibin Jianga,b,Mengyan Tangc,Zidi Xub,Yanan Wangb,Mopu Lib,Shuyin Zhengb,Jianghu Zhua,d,e,f,∗,Zhenlang Lina,d,e,f,∗,Min Zhanga,d,e,f,∗a Department of Pediatrics,the Second School of Medicine,the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University,Wenzhou,Zhejiang 325027,China.
